Evidence map›Paper›PMID 37186838›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Deciphering molecular mechanisms stabilizing the reovirus-binding complex.

Rita Dos Santos Natividade, Melanie Koehler, Priscila S F C Gomes, Joshua D Simpson, Sydni Caet Smith, Diego E B Gomes, Juliette de Lhoneux, Jinsung Yang, Ankita Ray, Terence S Dermody and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. UltrastrongScience advances · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Rita Dos Santos NatividadeLouvain Institute of Biomolecular Science and Technology, NanoBiophysics lab, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0002-0123-4760
Melanie KoehlerLouvain Institute of Biomolecular Science and Technology, NanoBiophysics lab, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0003-3042-1749
Priscila S F C GomesDepartment of Physics, Auburn University, Auburn, AL 36849.ORCID 0000-0001-7370-9596
Joshua D SimpsonLouvain Institute of Biomolecular Science and Technology, NanoBiophysics lab, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0002-8823-8130
Sydni Caet SmithDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, 37232 Nashville, TN.ORCID 0000-0002-3217-0843
Diego E B GomesDepartment of Physics, Auburn University, Auburn, AL 36849.ORCID 0000-0003-4855-040X
Juliette de LhoneuxLouvain Institute of Biomolecular Science and Technology, NanoBiophysics lab, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0003-1150-758X
Jinsung YangLouvain Institute of Biomolecular Science and Technology, NanoBiophysics lab, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0002-9731-1002
Ankita RayLouvain Institute of Biomolecular Science and Technology, NanoBiophysics lab, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0002-5059-9598
Terence S DermodyDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.ORCID 0000-0003-1853-8741
Rafael C BernardiDepartment of Physics, Auburn University, Auburn, AL 36849.ORCID 0000-0003-0758-2026
Kristen M OgdenDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, 37232 Nashville, TN.ORCID 0000-0002-2670-4335
David AlsteensLouvain Institute of Biomolecular Science and Technology, NanoBiophysics lab, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0001-9229-113X
UCLouvain · BEAuburn University · USVanderbilt University Medical Center · USLeibniz-Institute for Food Systems Biology at the Technical University of Munich · DEUniversity of Pittsburgh · USWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

Reovirus NeuropathogenesisR01AI174526 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TERENCE S. DERMODY · 2022 to 2026
$2.7M
Effects of Reoviridae assembly and transmission processes on viral genetic diversityR01AI155646 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OGDEN, KRISTEN M · 2021 to 2025
$2.5M
NIAID NIH HHS R01 AI155646NIAID NIH HHS R01 AI174526
6 · The paper itself

Abstract

Mammalian orthoreoviruses (reoviruses) serve as potential triggers of celiac disease and have oncolytic properties, making these viruses potential cancer therapeutics. Primary attachment of reovirus to host cells is mainly mediated by the trimeric viral protein, σ1, which engages cell-surface glycans, followed by high-affinity binding to junctional adhesion molecule-A (JAM-A). This multistep process is thought to be accompanied by major conformational changes in σ1, but direct evidence is lacking. By combining biophysical, molecular, and simulation approaches, we define how viral capsid protein mechanics influence virus-binding capacity and infectivity. Single-virus force spectroscopy experiments corroborated by in silico simulations show that GM2 increases the affinity of σ1 for JAM-A by providing a more stable contact interface. We demonstrate that conformational changes in σ1 that lead to an extended rigid conformation also significantly increase avidity for JAM-A. Although its associated lower flexibility impairs multivalent cell attachment, our findings suggest that diminished σ1 flexibility enhances infectivity, indicating that fine-tuning of σ1 conformational changes is required to successfully initiate infection. Understanding properties underlying the nanomechanics of viral attachment proteins offers perspectives in the development of antiviral drugs and improved oncolytic vectors.

Indexed as

OrthoreovirusReoviridaeAnimalsAntibodies, ViralCapsid ProteinsMammalsViral ProteinsVirus AttachmentAntibodies, ViralCapsid ProteinsViral Proteinsatomic force microscopybiophysicsglycanmolecular dynamicsvirus

Identifiers

PMID37186838
PMCPMC10214207
OpenAlexW4376602988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.